All Posts

Monthly Scientific Update – November 2022 (A recent study investigated the effects of PD-L1 expression on cancer cells and tumor-infiltrating immune cells in intrahepatic cholangiocarcinoma (CCA))
PD-L1 on Tumor-Infiltrating Immune Cells: A Potential Prognostic Biomarker for Cholangiocarcinoma Kelly Butler, Dr. Reham Abdel-Wahab Patients may develop cancer…
Patient Engagement and Cancer Genome Sequencing (PE-CGS) “Cancer Moonshot” Program
The research team at Washington University School of Medicine and the Alvin J. Siteman Cancer Center is partnering with the…

Five for Friday – Meet Five CCA Physicians
Home / Blog / [wpbb post:title] The Cholangiocarcinoma Foundation realizes that the fastest way to advance research is by working…

Five for Friday – Meet 5 CCA Scientists
Home / Blog / [wpbb post:title] Finding a cure for a disease as rare and complex as cholangiocarcinoma demands creative…

‘Think tank’ of multidisciplinary experts develop proposals to leverage precision medicine in improving cholangiocarcinoma patient outcomes
Cholangiocarcinoma Foundation sponsored C2T2 in Las Vegas with funding from a generous donor Twenty-nine expert scientists and clinicians from the…

Cure Cholangiocarcinoma Think Tank (C2T2)
The Cholangiocarcinoma Foundation has published a white paper from the first Cure Cholangiocarcinoma Think Tank (C2T2 ) meeting, which gathered…

Five for Friday – Meet Some of CCF's Valued Experts
Home / Blog / [wpbb post:title] Collaboration is essential for cholangiocarcinoma research. This month, join us in appreciating our medical…
Living with #CCAHope
At the 9th Annual Cholangiocarcinoma Foundation Conference, the communications team introduced a new social media campaign, "Living with #CCAHope." CCF…

Happy Thanksgiving Canada
Dear Friend, Last Canadian Thanksgiving, I enjoyed dinner with my family. It was a small gathering of my husband, mom,…

Five for Friday – 6 CCF Accomplished Medical Professionals
Home / Blog / [wpbb post:title] CCF collaborates with many physicians, clinicians, and researchers whose accomplishments in the cholangiocarcinoma field…